Hostname: page-component-745bb68f8f-s22k5 Total loading time: 0 Render date: 2025-02-11T08:45:24.326Z Has data issue: false hasContentIssue false

Epidemiological and pathological characteristics of Cutaneous Leishmaniasis from Baluchistan Province of Pakistan

Published online by Cambridge University Press:  23 December 2020

Aisha Khan
Affiliation:
Department of Biosciences, COMSATS University Islamabad, Park Road, Chak Shahzad, Islamabad, Pakistan
Rawan Sajid
Affiliation:
Department of Biosciences, COMSATS University Islamabad, Park Road, Chak Shahzad, Islamabad, Pakistan
Shaista Gul
Affiliation:
Department of histopathology, Bolan Medical Complex Hospital, Quetta, Pakistan
Ashiq Hussain
Affiliation:
Department of Microbiology, Bolan Medical Complex Hospital, Quetta, Pakistan
Mohammad Tahir Zehri
Affiliation:
Department of Microbiology, Bolan Medical Complex Hospital, Quetta, Pakistan
Shumaila Naz
Affiliation:
Department of Biological Sciences, National University of Medical Sciences (NUMS), Rawalpindi, Pakistan
Sami Simsek
Affiliation:
Department of Parasitology, Firat University, Elazig, Turkey
Shahid Waseem
Affiliation:
Alpha Genomics Pvt. Ltd. Plot 4-C, Danyal Plaza, Block A, Main Double Road, PWD, Islamabad, Pakistan
Muhammad Sohail Afzal
Affiliation:
Department of Life Sciences, University of Management & Technology (UMT), Lahore, Pakistan
Syed Kamran Ul Hassan Naqvi
Affiliation:
Department of Biosciences, COMSATS University Islamabad, Park Road, Chak Shahzad, Islamabad, Pakistan
Muhammad Qasim
Affiliation:
Department of Economics, Finance and Statistics, Jönköping International Business School, Jönköping University, Jönköping, Sweden
Haroon Ahmed*
Affiliation:
Department of Biosciences, COMSATS University Islamabad, Park Road, Chak Shahzad, Islamabad, Pakistan
*
Author for correspondence: Haroon Ahmed, E-mail: haroonahmad12@yahoo.com

Abstract

Cutaneous Leishmaniasis (CL) is considered a neglected tropical disease which in Pakistan can now be considered as a growing public health problem. The exact figures on the magnitude of the disease are lacking both at the national and regional level and only a few health centres are available for diagnosis of CL. The present study was designed to identify the epidemiology of CL infection from August 2018 to December 2019 and to assess clinical aspects of CL in Baluchistan Province of Pakistan. A total of 4072 clinically suspected CL cases were analysed statistically. The highest number of CL cases were reported in May, followed by April, January and then July, February and June and the lowest number of cases were observed in March and November. The highest prevalence rate was found in males where 38% of reported cases were aged 0–9 years. The majority (24.4%) of lesions were found on the hands followed by the face in which cheeks, ears and nose were the effected organs. About 50% of the participants have single lesion while 14% of the participants had two and nearly 3% of the participants have six lesions. The atypical clinical presentations were observed in Baluchistan and common unusual presentations were lupus erythematosus. The study findings suggest that more epidemiological studies and health education campaigns are needed for the population awareness regarding CL in Baluchistan. It is recommended that risk factors should be evaluated to establish control and management strategies to prevent disease at the individual and community level.

Type
Research Article
Copyright
Copyright © The Author(s), 2020. Published by Cambridge University Press

Introduction

Leishmaniasis is a group of parasitic infections caused by flagellate protozoans of genus Leishmania that are transmitted through the bite of infected female phlebotomine sand fly (Elmahallawy et al., Reference Elmahallawy, Martínez, Rodriguez-Granger, Hoyos-Mallecot, Agil, Mari and Fernández2014). More than 20 species of Leishmania are capable of causing the disease (Georgiadou et al., Reference Georgiadou, Makaritsis and Dalekos2015; WHO, 2020) with clinical manifestations including Cutaneous Leishmaniasis (CL), Mucocutaneous Leishmaniasis, Diffuse Cutaneous Leishmaniasis and Visceral Leishmaniasis (also known as kala-azar) (Desjeux, Reference Desjeux2004; WHO, 2010; Ghatee et al., Reference Ghatee, Taylor and Karamian2020). Leishmaniasis has been reported in 98 countries affecting about 350 million people worldwide, making it one of the seven most common as well important neglected tropical diseases (Torres-Guerrero et al., Reference Torres-Guerrero, Quintanilla-Cedillo, Ruiz-Esmenjaud and Arenas2017; de Souza et al., Reference de Souza, Marins, Mathias, Monteiro, Yukuyama, Scarim, Löbenberg and Bou-Chacra2018). CL being the most common and widely distributed variety claims between 0.7 and 1.2 million cases reported worldwide annually (Alvar et al., Reference Alvar, Vélez, Bern, Herrero, Desjeux, Cano, Jannin and den Boer2012). About 95% of the incidents are reported from three epidemiological regions i.e. South America, the Mediterranean Basin and spread throughout the Middle East to Central Asia (Torres-Guerrero et al., Reference Torres-Guerrero, Quintanilla-Cedillo, Ruiz-Esmenjaud and Arenas2017). More than 85% of new CL cases appeared in Afghanistan, Algeria, Bolivia, Brazil, Colombia, Iran, Iraq, Pakistan, the Syrian Arab Republic and Tunisia during 2018 (Zijlstra, Reference Zijlstra2016; WHO, 2020).

CL is highly endemic in Pakistan and spread extensively due to massive out-migration from endemic to non-endemic areas and vice versa (Kassi et al., Reference Kassi, Kassi, Afghan, Rehman and Kasi2008). CL affects people of low social-economic status and is associated with undernutrition, population displacement, lack of shelter and a weak immune system (WHO, 2010). The burden of disease in Pakistan has been reported to be surpassed by 400 000 cases reported in 2016 that makes about 10% of CL cases globally (Blum et al., Reference Blum, Desjeux, Schwartz, Beck and Hatz2004) with both anthroponotic (ACL) and zoonotic (ZCL) forms of CL (Alvar et al., Reference Alvar, Vélez, Bern, Herrero, Desjeux, Cano, Jannin and den Boer2012). ACL occasionally occurring due to Leishmania tropica, is widespread and most grave public health problem in Pakistan (Hussain et al., Reference Hussain, Munir, Khan, Khan, Ayaz, Jamal, Ahmed, Aziz, Watany and Kasbari2018). The urban areas of Punjab and Sindh provinces are of high CL endemicity (Iftikhar et al., Reference Iftikhar, Bari and Ejaz2003; Kakarsulemankhel, Reference Kakarsulemankhel2004; Katakura, Reference Katakura2009), the Afghan refugee camps in Northwest Frontier Province, now called Khyber Pakhtunkhwa (Simon Brooker et al., Reference Simon Brooker, Adil, Agha, Reithinger, Rowland, Ali and Kolaczinski2004) and the surrounding tribal belt of Federally Administrated Tribal Areas (FATA) (Khan et al., Reference Khan, ul Bari, Hashim, Khan, Muneer, Shah, Wahid, Yardley, O'Neil and Sutherland2016; Qureshi et al., Reference Qureshi, Ali, Rashid and Ali2016; Irum et al., Reference Irum, Aftab, Khan, Naz, Simsek, Habib, Afzal, Nadeem, Qasim and Ahmed2021). CL is also widely distributed in sub-urban localities of Baluchistan province (Bhutto et al., Reference Bhutto, Soomro, Baloch, Matsumoto, Uezato, Hashiguchi and Katakura2009; Ejaz et al., Reference Ejaz, Raza, Din and Bux2008; Hussain et al., Reference Hussain, Munir, Khan, Khan, Ayaz, Jamal, Ahmed, Aziz, Watany and Kasbari2018), Gilgit Baltistan (Ayub et al., Reference Ayub, Gramiccia, Khalid, Mujtaba and Bhutta2003), Azad Jammu and Kashmir (Mughal, Reference Mughal2014; Shaheen et al., Reference Shaheen, Qureshi, Qureshi, Fatima, Afzal and Alhewairini2020). The ZCL type, caused by Leishmania major, has its reservoir populations in feral animals predominantly gerbils such as Rhombomys opimus in rural and sub-urban localities of Punjab, Baluchistan and Sindh provinces (Bhutto et al., Reference Bhutto, Soomro, Nonaka and Hashiguchi2003; Afghan et al., Reference Afghan, Kassi, Kasi, Ayub, Kakar and Marri2011).

Leishmaniasis has diverse clinical manifestations and may appear similar to a large variety of other conditions (Afghan et al., Reference Afghan, Kassi, Kasi, Ayub, Kakar and Marri2011; Antinori et al., Reference Antinori, Schifanella and Corbellino2012). CL is identified by the appearance of one or more well-defined ulcerous lesions (Bacellar et al., Reference Bacellar, Lessa, Schriefer, Machado, de Jesus, Dutra, Gollob and Carvalho2002; Carvalho et al., Reference Carvalho, Filho, Falcao, Rocha Lima and Gontijo2008), usually found on uncovered areas of the body i.e. forearms, legs and face where sand-fly bites occur most often (Salman et al., Reference Salman, Rubeiz and Kibbi1999; Chaudhary et al., Reference Chaudhary, Bilimoria and Katare2008). After 4–12 weeks of a bite, a small erythematous papule appears at the bite site which gives off a seropurulent discharge, which later on dries up and then a ‘volcanic’ nodulo-ulcer appear which is classical for CL (Iddawela et al., Reference Iddawela, Vithana, Atapattu and Wijekoon2018). These lesions can develop into other morphological forms such as lupoid, keloidal, psoriasiform, erysipeloid, verrucous, zosteriform, tumorous, eczematoid and acneform (Bari and Raza, Reference Bari and Raza2010; Shamsuddin et al., Reference Shamsuddin, Mengal, Gazozai, Mandokhail, Kasi, Muhammad and Ahmad2017; Iddawela et al., Reference Iddawela, Vithana, Atapattu and Wijekoon2018). Routinely used diagnostic methods are direct clinical observations and micro-scopical examination of lesion aspiration samples. Alternative diagnostic options include histopathology and polymerase chain reaction (PCR) but due to the low frequency of parasites, PCR may give false-negative results. The practice of using PCR as a diagnostic tool is also uncommon worldwide and not easily applied to clinical health settings (Weirather et al., Reference Weirather, Jeronimo, Gautam, Sundar, Kang, Kurtz, Haque, Schriefer, Talhari, Carvalho and Donelson2011; Tsukayama et al., Reference Tsukayama, Núñez, De Los Santos, Soberón, Lucas, Matlashewski, Llanos-Cuentas, Ore, Baldeviano, Edgel and Lescano2013; de Paiva-Cavalcanti et al., Reference de Paiva-Cavalcanti, de Morais, Pessoa-e-Silva, Trajano-Silva, da Cunha Gonçalves-de-Albuquerque, Tavares, Brelaz-de-Castro, e Silva and Pereira2015). The sensitivity of enzyme-linked immunosorbent assay is 50% in the case of co-infection due to less circulating antibodies in blood (Sinha et al., Reference Sinha, Pandey and Bhattacharya2005; de Souza et al., Reference de Souza, Veras, Welby-Borges, Silva, Leite, Ferraro, Meyer-Fernandes, Barral, Costa and de Freitas2011; Abeijon et al., Reference Abeijon, Kashino, Silva, Costa, Fujiwara, Costa and Campos-Neto2012). The treatment relies on chemotherapy and the first line of treatment for all types of leishmaniasis are the medications containing pentavalent antimonials such as sodium stibogluconate and meglumine antimoniate. But unfortunately, the treatment failure has been reported for this class of drug because the parasite has shown resistance to this class of drug and its authenticity and clinical value has been challenged (Croft et al., Reference Croft, Sundar and Fairlamb2006; Llanos-Cuentas et al., Reference Llanos-Cuentas, Tulliano, Araujo-Castillo, Miranda-Verastegui, Santamaria-Castrellon, Ramirez, Lazo, De Doncker, Boelaert, Robays and Dujardin2008).

CL is one of the neglected diseases in Pakistan and exact figures on the magnitude of the disease are lacking both at national and regional levels and only a few health centres are available for diagnosis of CL. The limitation/absence in the diagnosis and treatment increase the need for an epidemiological survey of the disease in the country (Afghan et al., Reference Afghan, Kassi, Kasi, Ayub, Kakar and Marri2011). Despite the disease endemicity, the information regarding the epidemiology of CL in Pakistan is incomplete (Khan et al., Reference Khan, ul Bari, Hashim, Khan, Muneer, Shah, Wahid, Yardley, O'Neil and Sutherland2016). Baluchistan is one of the provinces located in the southwest of Pakistan and its geographical distribution has made it a camping ground for sand-fly due to disturbances of the habitats and deforestation (Firdous et al., Reference Firdous, Yasinzai and Ranja2009). Because of the major teaching and tertiary care hospitals located in Quetta, most of CL patients have been reported in Quetta (Kassi and Kasi, Reference Kassi and Kasi2005). This may be due to mass migration from adjoining areas of Afghanistan and the absence of field epidemiological surveys (Shakila et al., Reference Shakila, Bilqees, Salim and Moinuddin2006).

The present study was designed with an aim to identify epidemiology and to assess clinical aspects of CL in Baluchistan Province of Pakistan.

Materials and methods

Study area

The study was carried out in different districts of Baluchistan covering the surface area of 347 190 km2 and constituting 44% of Pakistan's total landmass located between 30.12N and 67.01E. It has borders to Afghanistan from the north and north-west and to Iran from the south-west and has a population of around 10 million inhabitants predominantly (76%) rural. Physically, the topography is diverse and divided into four distinct zones: upper highlands, lower highlands, plains and deserts altitude ranging from 600 m from the valley floor to 3700 m above the mean sea levels. The climate varied from semi-arid summers to semi-arid winter with temperature as high as 50°C and as low as 1°C where the annual average temperature is about 19°C and average annual rainfall for Quetta is 44 millimetres (Kakarsulemankhel, Reference Kakarsulemankhel2004) (Table 1).

Table 1. Description of the study sites

masl, meters above sea level; Total HUs, Total housing units; T min, minimum temperature; T max, maximum temperature.

Epidemiological investigation

Due to the lack of ground-level research and treatment limitations, the epidemiological status of CL in the study area was not known. Based on university hospital records between August 2018 and December 2019, 4072 cases of CL were reported from the Baluchistan.

Ethics statement

The study was approved by the IRB & Ethics Committee of National University of Medical Sciences (NUMS), Rawalpindi, Pakistan under reference number 06/R&D/NUMS.

Sample collection and microscopy

A total of 4072 clinically suspected cases of CL visited the Department of Microbiology, Bolan Medical College, Quetta from different areas of Baluchistan. The selected patients were photographed and specific medical explanations for these lesions were obtained from the dermatologist. The samples were collected from the patients after both written and verbal informed consent was obtained. The lesion sample from CL patients was obtained using needle aspiration method. The overlying dry scab was rubbed off with an alcohol gauze pad and approximately 0.1–0.2 mL sterile saline solution injected into the lesion and aspiration fluid was obtained. The slides of smears from each patient were fixed with absolute methyl alcohol and stained with Giemsa stain for parasitological investigation. The slides were examined under the light microscope at 100× magnification for the presence of Leishmania spp. amastigotes (Kassi et al., Reference Kassi, Tareen, Qazi and Kasi2004).

Statistical analysis

The CL data were documented into Microsoft Excel and analysed using SPSS (SPSS Inc., Chicago, Illinois, USA) version 26.0. Prevalence of CL in different age groups and gender was calculated. The Chi-square test (χ 2) and frequencies of demographic characteristic were used for categorical data. Monthly distribution of CL cases for the years of 2018 and 2019 was calculated in form of percentage. Moreover, the prevalence of CL by age groups with 95% confidence limits were analysed. The statistical significance was set for all statistical tests at P value <0.05 (two-sided).

Results

In the present study, a total of 4072 individuals comprising both males and females were studied from the period of August 2018 to December 2019 and analysed with respect to age, gender and body parts affected by CL.

Clinical features of CL patients

Of the 4072 CL cases, 50.6% (2062/4072) were positive by direct microscopy. The effect of CL in a different age group is depicted in Fig. 1a–f. The lesions were more prevalent among young individuals as compared to older adults. Exposed parts of the body (hand, cheeks and nose) were the main affected areas. Different clinical forms were observed based on clinical morphology of the CL patients' lesion. These lesions diverge from mild to moderate papulonodular form which is <1 cm in diameter to more severe and complex forms. One of the forms was dry type papulonodular lesions with erythematous smooth and superficial papule on the face and size varied from 0.5 to 1 cm (Fig. 1a). Other form presented the clinically infiltrated ulceration which was ulcerated lesion and present the dry type (Fig. 1b). Among CL patients, lupus erythematosus was most common with unusual presentations ranging from scaly and crusted plaque to enlarged erythematous and infiltrated plaque on the elbow wrapped with white and dry scales mimicking psoriasis (Fig. 1c, d and e). A psoriasiform lesion was also observed on the nose of a CL patient which was characterized by an infiltrated plaque (Fig. 1f).

Fig. 1. (a–f) Atypical forms of Cutaneous Leishmaniasis (CL) lesions. (a) Papulonodular lesions, dry type; (b) Ulcerated lesion, dry type; (c) Discoid lupus erythematosus, dry type; (d) Psoriasiform lesion, dry type; (e) Mycetomatous, dry type; (f) Erysipeloid, dry type.

Age and gender-wise distribution of CL

In the present study, the total number of people infected with CL from August to December 2018 was 969. Of the total, 55.3% (536/969) of them were males while 44.7% (433/969) were females. The highest percentage (38%, 368/969) of CL patients was observed aged between 0 and9 years followed by age group 10–19 years which included 29.6% (287/969) of the cases. However, the lowest proportion (6.9%, 67/969) was observed at 30–39 years old (Table 2).

Table 2. Distribution and prevalence of CL in different age groups and gender for the years 2018 and 2019

The total number of people infected with CL during the year 2019 was 3103 with the overall CL infection rate during the year 2019 was higher in males (55.9%, 1735/3103) than females (44.1%, 1368/3103). The highest percentage (40.1%, 1245/3103) was observed at 0–9 years old. Only 28.8% (895/3103) of CL patients were observed in 10–19 years old participants followed by 13.1% (406/3103) in 20–29 years old, 6.5% (202/3103) in 30–39 and 11.4% (355/3103) in 40+ years old (Table 2). Based on different age groups, the frequency of males to females CL patients was different. Males (22.4%), (16.44%) and (8.22%) were affected more than females (17.72%), (12.41%) and (4.87%) at the age of 0–9, 10–19 and 20–29 years, respectively. On the other hand, the disease was higher in females (3.22%) and (5.87%) than males (0.29%) and (0.58%) at the age of 30–39 and 40+ years as represented in Fig. 2.

Fig. 2. Prevalence of CL according to gender and age Left: Prevalence of CL by age groups with 95% confidence limits for the year 2019. Right: Prevalence of CL by age groups with 95% confidence limits for the year 2018.

Year wise prevalence of CL in different age groups and gender

The findings of the present study revealed that of the total population tested from the period of August–December 2018, 55.3% (536/969) were males and 44.7% (433/969) were females. In total, 41.3% (400/969) of participants were tested positive for lesion aspiration test. Out of which 39.6% (212/536) of males and 43.4% (188/433) of females were positive for lesion aspiration test. The highest percentage (45.3% and 46.8%) in positive lesion aspiration test was found among the participants aged between 0 and 9 years in both males and females, respectively (Table 2). It was observed that the lesion aspiration test was not significantly different by age or gender of participants studied.

In the year 2019, 55.3% (1735/3103) of participants were males and 44.7% (1368/3103) were females. A total of 53% of participants were tested positive for lesion aspiration test and among these 53.4% (927/1735) were males and 53.7% (735/1368) were females. The highest frequency (57%) of lesion aspiration test was tested positive between age 0 and 9 years regardless of age and gender and lowest frequency (47% and 45%) was observed of the participants aged between 30 and 39 years for both males and females, respectively (Table 2).

Site-specific distribution of lesion

The majority 24.4% (757/3103) of lesions were found on the hands followed by face in which cheeks, ears and nose were most affected. The number of lesions per person ranged from 1 to 6 (Fig. 3). Approximately 50% of the participants had single lesion while 14% of the participants had two and nearly 3% of the participants have six lesions during the study period of 2018 and 2019. Most of the lesions were erythematosus with unusual presentations ranging from scaly and crusted plaque to enlarged erythematous and infiltrated plaque.

Fig. 3. Number and percentageof male and female patients with active lesions in 2018 and 2019.

Month-wise distribution of CL

The findings of the study revealed that highest number of CL cases (23.6%, 229/969) was found in December followed by October (22%, 213/969) and August (21.9%, 212/969) during the year 2018. During the year 2019, the highest number of CL cases were observed in May (16.6%, 514/3103) followed by April (13.5%, 418/3103), January (12.5%, 388/3103) and then July (9.6%, 298/3103), February (8.7%, 271/3103) and June (8.5%, 264/3103). The lowest number of CL cases were observed in March (2.7%, 85/3103) and November (3.7%, 116/3103) (Table 3).

Table 3. Monthly distribution of CL cases for the years of 2018 and 2019

Discussion

CL is one of the prevalent vector-borne diseases in Pakistan which affects people with lower income and is linked to poor housing conditions, migration, inadequate nutrition, vector control failures and immuno-compromised conditions like HIV/AIDS (Alvar et al., Reference Alvar, Yactayo and Bern2006). CL has been reported from all over Pakistan specially from native surrounding areas of FATA and KPK (Khan et al., Reference Khan, ul Bari, Hashim, Khan, Muneer, Shah, Wahid, Yardley, O'Neil and Sutherland2016; Qureshi et al., Reference Qureshi, Ali, Rashid and Ali2016; Khan et al., Reference Khan, Afzal and Ahmed2019), urban-rural areas of Sindh and Punjab (Iftikhar et al., Reference Iftikhar, Bari and Ejaz2003), Azad Jammu and Kashmir (Mughal, Reference Mughal2014; Shaheen et al., Reference Shaheen, Qureshi, Qureshi, Fatima, Afzal and Alhewairini2020) and sub-urban localities of Baluchistan province (Bhutto et al., Reference Bhutto, Soomro, Nonaka and Hashiguchi2003; Ejaz et al., Reference Ejaz, Raza, Din and Bux2008; Rahman and Rehman, Reference Rahman and Rehman2017). It is presumed that uninfected regions with the borders adjacent to endemic areas are at risk and colonization of a large number of populations in areas where sand-fly is endemic is one of the reasons of CL outbreaks (Simon Brooker et al., Reference Simon Brooker, Adil, Agha, Reithinger, Rowland, Ali and Kolaczinski2004).

The current study has been conducted in Baluchistan province which is a high-altitude region and borders to Afghanistan and Iran where CL is endemic (Ghatee et al., Reference Ghatee, Taylor and Karamian2020). The studied area has the highest CL prevalence rate where dominant specie is L. tropica and in addition about 1500 cases of CL were reported in Afghan refugee camps in Pakistan in 2002 (Kakarsulemankhel, Reference Kakarsulemankhel2004). In another study Rahman and Rehman (Reference Rahman and Rehman2017) also reported a significantly high level of CL among Afghans compared to the local Pakistani population (32.5% vs 20.3%). However, the prevalence of CL due to L. major has also been reported from the Southern part of Baluchistan (Bhutto et al., Reference Bhutto, Soomro, Baloch, Matsumoto, Uezato, Hashiguchi and Katakura2009). Thus, the present study was designed for the aim of identifying the epidemiology and assessing the clinical aspects of CL in Baluchistan.

In the current study, CL infection is more prevalent in males (55%) as compared to females with similar findings reported by Shaheen et al. (Reference Shaheen, Qureshi, Qureshi, Fatima, Afzal and Alhewairini2020) in Azad Jammu and Kashmir, by Galgamuwa et al. (Reference Galgamuwa, Sumanasena, Yatawara, Wickramasinghe and Iddawela2017) in Sri Lanka, by Aara et al. (Reference Aara, Khandelwal, Bumb, Mehta, Ghiya, Jakhar, Dodd, Salotra and Satoskar2013) in India by Alavinia et al. (Reference Alavinia, Arzamani, Reihani and Jafari2009) and in Iran. It may be due to the reason that activities of the males are mostly out-door and have maximum chances of being bitten by sand fly while females are confined to indoor activities (Gadisa et al., Reference Gadisa, Tsegaw, Abera, Elnaiem, den Boer, Aseffa and Jorge2015). The current study indicated that 38% of reported CL cases were in children aged 0–9 years followed by adults 10–19 years of age with a prevalence rate of 29% and is in concordance with other studies (Kakarsulemankhel, Reference Kakarsulemankhel2004; Aara et al., Reference Aara, Khandelwal, Bumb, Mehta, Ghiya, Jakhar, Dodd, Salotra and Satoskar2013; Qureshi et al., Reference Qureshi, Ali, Rashid and Ali2016; Yohannes et al., Reference Yohannes, Abebe and Boelee2019; Shaheen et al., Reference Shaheen, Qureshi, Qureshi, Fatima, Afzal and Alhewairini2020). This might be due to a weak immune system and food deprivation of children (Zijlstra, Reference Zijlstra2016). In contrast to this, Aara et al. (Reference Aara, Khandelwal, Bumb, Mehta, Ghiya, Jakhar, Dodd, Salotra and Satoskar2013) reported a higher prevalence of CL cases in 21–30 years age group whereas in our study lower cases of CL were found in 30–39 years old and 40+ as also reported by Nawaz et al. (Reference Nawaz, Khan, Khan and Rauf2010). As lifelong immunity develops following infection with CL, it is understandable why infection is more common in young individuals.

In the present study, most CL cases appeared to have localized symptoms and most lesions were present on the exposed parts of the body particularly hands, nose, ears and cheeks. Similar results were observed in studies carried out in Ethiopia and Turkey where most of the lesions also appeared on the face (Bari, Reference Bari2008; Uzun et al., Reference Uzun, Gürel, Durdu, Akyol, Fettahlıoğlu Karaman, Aksoy, Aytekin, Borlu, İnan Doğan, Doğramacı and Kapıcıoğlu2018; Yohannes et al., Reference Yohannes, Abebe and Boelee2019). For the locations of the lesions, it is of the opinion that it is difficult to cover up the face and is exposed for biting of sand flies at night-time which is a crucial time for the parasite spread (Aara et al., Reference Aara, Khandelwal, Bumb, Mehta, Ghiya, Jakhar, Dodd, Salotra and Satoskar2013). Correspondingly to the findings of Özbilgin et al. (Reference Özbilgin, Töz, Harman, Topal, Uzun, Okudan, Güngör, Erat, Ertabaklar, Ertuğ and Gündüz2019), 77% lesion appeared on uncovered parts of the body. In the present findings, the common unusual presentations were lupus erythematosus followed by the papulonodular lesion, ulcerated lesion and less common psoriasiform lesion. In CL, atypical clinical presentations were progressively observed in Pakistan and it has been speculated that limitations of these atypical cases in certain geographical regions could be due to new strain of Leishmania parasite (Bari, Reference Bari2008). In our study, approximately 50% of the CL cases had a single lesion, 14% had two lesions and remaining had three to six lesions. Our results were similar to the findings of Shaheen et al. (Reference Shaheen, Qureshi, Qureshi, Fatima, Afzal and Alhewairini2020) who also reported the presence of the single lesion in 56% of the CL cases. Other studies conducted by Talari et al. (Reference Talari, Talaei, Shajari, Vakili and Taghaviardakani2006) and Qureshi et al. (Reference Qureshi, Ali, Rashid and Ali2016) also showed the highest number of single lesions in CL cases. CL cases with two or more lesions on the body might be due to exposure to the sandflies for a long time.

Although CL cases were reported throughout the entire year, the highest number of cases were detected in May, followed by April, January and then July, February and June. The lowest number of cases was during March and November. Similar findings have been reported by Shaheen et al. (Reference Shaheen, Qureshi, Qureshi, Fatima, Afzal and Alhewairini2020) that warm months are the peak season of CL in Pakistan. This could be due to the reason that sand flies are more active during the warm weather and consumes more blood for the development of their eggs. The current study has shown rising drift in the number of CL cases in Baluchistan and is a disease of public health importance. It is suggestive that different atypical clinical forms of CL depend on host immune response, number and site of parasites inoculated and host nutritional status (Bari, Reference Bari2008). The study highlights the importance of early detection of erythematic skin lesion and proper management and treatment of CL to prevent a future outbreak of the disease especially in areas where leishmaniasis is endemic. The study also suggests that the use of insecticides, bed nets and new therapies for parasite can also help in the control of leishmaniasis.

Concluding remarks

In conclusion, the current findings suggest that more epidemiological studies are needed in Baluchistan and health education campaigns for population awareness regarding the CL. It is recommended to evaluate the risk factors and to establish control and management strategies to prevent disease at an individual and community level in Baluchistan. It is also recommended to conduct further reservoir studies to understand the vertical transmission of disease among various hosts.

Data

Raw data cannot be made publicly available due to ethical restrictions imposed by the Institutional Ethical Committee on human rights related to research. However, data can be provided on request.

Authors' contributions

HA designed and supervised the study. AK and RS collected the data, drafted and wrote the manuscript along with SN. AH, SG and MTZ contributed to data and sample collection. MQ did the statistical analysis. SS revised the manuscript along with MSA. All authors read and approved the final manuscript.

Financial support

This research was partially supported by Pakistan Science Foundation under Project No. PSF-TUBITAK/Med /P-NUMS(09).

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical standards

All procedures performed in studies involving human participants were in accordance with the ethical standards. The study was approved by the IRB & Ethics Committee under project ‘A new and combined approach for the diagnosis of cutaneous leishmaniasis, a neglected vector-borne disease’ and letter reference number 06/R&D/NUMS.

References

Aara, N, Khandelwal, K, Bumb, RA, Mehta, RD, Ghiya, BC, Jakhar, R, Dodd, C, Salotra, P and Satoskar, AR (2013) Clinco-epidemiologic study of cutaneous leishmaniasis in Bikaner, Rajasthan, India. American Journal of Tropical Medicine and Hygiene 89, 111115.CrossRefGoogle ScholarPubMed
Abeijon, C, Kashino, SS, Silva, FO, Costa, DL, Fujiwara, RT, Costa, CH and Campos-Neto, A (2012) Identification and diagnostic utility of Leishmania infantum proteins found in urine samples from patients with visceral leishmaniasis. Clinical and Vaccine Immunology 19, 935943.CrossRefGoogle ScholarPubMed
Afghan, AK, Kassi, M, Kasi, PM, Ayub, A, Kakar, N and Marri, SM (2011) Clinical manifestations and distribution of cutaneous leishmaniasis in Pakistan. Journal of Tropical Medicine 359145, 8 pages.Google Scholar
Alavinia, SM, Arzamani, K, Reihani, MH and Jafari, J (2009) Some epidemiological aspects of cutaneous leishmaniasis in Northern Khorasan Province, Iran. Journal of Arthropod-Borne Diseases 3, 50.Google ScholarPubMed
Alvar, J, Yactayo, S and Bern, C (2006) Leishmaniasis and poverty. Trends in Parasitology 22, 552557.CrossRefGoogle ScholarPubMed
Alvar, J, Vélez, ID, Bern, C, Herrero, M, Desjeux, P, Cano, J, Jannin, J and den Boer, M and WHO Leishmaniasis Control Team (2012) Leishmaniasis worldwide and global estimates of its incidence. PLoS ONE 7, e35671.CrossRefGoogle ScholarPubMed
Antinori, S, Schifanella, L and Corbellino, M (2012) Leishmaniasis: new insights from an old and neglected disease. European Journal of Clinical Microbiology & Infectious Diseases 31, 109118.CrossRefGoogle ScholarPubMed
Ayub, S, Gramiccia, M, Khalid, M, Mujtaba, G and Bhutta, RA (2003) Cutaneous leishmaniasis in Multan: species identification. Journal of Pakistan Medical Association 53, 445447.Google ScholarPubMed
Bacellar, O, Lessa, H, Schriefer, A, Machado, P, de Jesus, AR, Dutra, WO, Gollob, KJ and Carvalho, EM (2002) Up-regulation of Th1-type responses in mucosal leishmaniasis patients. Infection and Immunity 70, 67346740.CrossRefGoogle ScholarPubMed
Bari, AU (2008) Clinical spectrum of nasal leishmaniasis in Muzaffarabad. Journal of College of Physicians and Surgeons Pakistan 19, 146149.Google Scholar
Bari, AU and Raza, N (2010) Lupoid cutaneous leishmaniasis: a report of 16 cases. Indian Journal of Dermatology, Venereology and Leprology 76, 85.CrossRefGoogle Scholar
Bhutto, AM, Soomro, RA, Nonaka, S and Hashiguchi, Y (2003) Detection of new endemic areas of cutaneous leishmaniasis in Pakistan: a 6-year study. International Journal of Dermatology 42, 543548.CrossRefGoogle ScholarPubMed
Bhutto, AM, Soomro, FR, Baloch, JH, Matsumoto, J, Uezato, H, Hashiguchi, Y and Katakura, K (2009) Cutaneous leishmaniasis caused by Leishmania (L.) major Infection in Sindh province, Pakistan. Acta Tropica 111, 295298.CrossRefGoogle ScholarPubMed
Blum, J, Desjeux, P, Schwartz, E, Beck, B and Hatz, C (2004) Treatment of cutaneous leishmaniasis among travellers. Journal of Antimicrobial Chemotherapy 53, 158166.CrossRefGoogle ScholarPubMed
Carvalho, GM, Filho, JDA, Falcao, AL, Rocha Lima, AC and Gontijo, CM (2008) Naturally infected Lutzomyia sand flies in a Leishmania-endemic area of Brazil. Vector-Borne and Zoonotic Diseases 8, 407414.CrossRefGoogle Scholar
Chaudhary, RG, Bilimoria, FE and Katare, SK (2008) Diffuse cutaneous leishmaniasis: co-infection with human immunodeficiency virus (HIV). Indian Journal of Dermatology, Venereology and Leprology 74, 641.CrossRefGoogle Scholar
Croft, SL, Sundar, S and Fairlamb, AH (2006) Drug resistance in leishmaniasis. Clinical Microbiology Reviews 19, 111126.CrossRefGoogle ScholarPubMed
de Paiva-Cavalcanti, M, de Morais, RCS, Pessoa-e-Silva, R, Trajano-Silva, LAM, da Cunha Gonçalves-de-Albuquerque, S, Tavares, DDHC, Brelaz-de-Castro, MCA, e Silva, RDF and Pereira, VRA (2015) Leishmaniases diagnosis: an update on the use of immunological and molecular tools. Cell & Bioscience 5, 31.CrossRefGoogle ScholarPubMed
Desjeux, P (2004) Leishmaniasis: current situation and new perspectives. Comparative Immunology, Microbiology & Infectious Diseases 27, 305318.CrossRefGoogle ScholarPubMed
de Souza, VL, Veras, PS, Welby-Borges, M, Silva, T, Leite, BR, Ferraro, RB, Meyer-Fernandes, JR, Barral, A, Costa, JML and de Freitas, LA (2011) Immune and inflammatory responses to Leishmania amazonensis isolated from different clinical forms of human leishmaniasis in CBA mice. Memórias do Instituto Oswaldo Cruz 106, 2331.CrossRefGoogle Scholar
de Souza, A, Marins, DSS, Mathias, SL, Monteiro, LM, Yukuyama, MN, Scarim, CB, Löbenberg, R and Bou-Chacra, NA (2018) Promising nanotherapy in treating leishmaniasis. International Journal of Pharmaceutics 547, 421431.CrossRefGoogle ScholarPubMed
Ejaz, A, Raza, N, Din, QU and Bux, H (2008) Outbreak of cutaneous leishmaniasis in Somniani, Balochistan–implementation of preventive measures for deployed personnel of armed forces. Journal of Pakistan Association of Dermatologist 18, 220225.Google Scholar
Elmahallawy, EK, Martínez, AS, Rodriguez-Granger, J, Hoyos-Mallecot, Y, Agil, A, Mari, JMN and Fernández, JG (2014) Diagnosis of leishmaniasis. Journal of Infection in Developing Countries 8, 961972.CrossRefGoogle ScholarPubMed
Firdous, R, Yasinzai, M and Ranja, K (2009) Efficacy of glucantime in the treatment of Old World cutaneous leishmaniasis. International Journal of Dermatology 48, 758762.CrossRefGoogle ScholarPubMed
Gadisa, E, Tsegaw, T, Abera, A, Elnaiem, DE, den Boer, M, Aseffa, A and Jorge, A (2015) Eco-epidemiology of visceral leishmaniasis in Ethiopia. Parasites and Vectors 8, 381.CrossRefGoogle ScholarPubMed
Galgamuwa, LS, Sumanasena, B, Yatawara, L, Wickramasinghe, S and Iddawela, D (2017) Clinico-Epidemiological patterns of Cutaneous Leishmaniasis patients attending the Anuradhapura teaching hospital, Sri Lanka. Korean Journal of Parasitology 55, 1.CrossRefGoogle ScholarPubMed
Georgiadou, SP, Makaritsis, KP and Dalekos, GN (2015) Leishmaniasis revisited: current aspects on epidemiology, diagnosis and treatment. Journal of Translational Medicine 3, 4350.Google Scholar
Ghatee, MA, Taylor, WR and Karamian, M (2020) The geographical distribution of Cutaneous Leishmaniasis causative agents in Iran and its neighboring countries, a review. Frontiers in Public Health 8, 11.CrossRefGoogle ScholarPubMed
Hussain, M, Munir, S, Khan, TA, Khan, A, Ayaz, S, Jamal, MA, Ahmed, I, Aziz, S, Watany, N and Kasbari, M (2018) Epidemiology of cutaneous leishmaniasis outbreak, Waziristan, Pakistan. Emerging Infectious Diseases 24, 159.CrossRefGoogle ScholarPubMed
Iddawela, D, Vithana, SMP, Atapattu, D and Wijekoon, L (2018) Clinical and epidemiological characteristics of cutaneous leishmaniasis in Sri Lanka. BMC Infectious Diseases 18, 108.CrossRefGoogle ScholarPubMed
Iftikhar, N, Bari, I and Ejaz, A (2003) Rare variants of cutaneous leishmaniasis: whitlow, paronychia and sporotrichoid. International Journal of Dermatology 42, 807809.CrossRefGoogle ScholarPubMed
Irum, S, Aftab, M, Khan, A, Naz, S, Simsek, S, Habib, A, Afzal, MS, Nadeem, MA, Qasim, M and Ahmed, H (2021) Cutaneous Leishmaniasis (CL): a cross-sectional community based survey on knowledge, attitude and practices in a highly endemic area of Waziristan (KPK Province), Pakistan. Acta Tropica 213, 105746.CrossRefGoogle Scholar
Kakarsulemankhel, JK (2004) Present situation of cutaneous leishmaniasis in Balochistan, Pakistan. Pakistan Journal of Biological Sciences 7, 698702.Google Scholar
Kassi, M and Kasi, PM (2005) Diagnosis of cutaneous leishmaniasis by fine needle aspiration cytology: a report of 66 cases. Tropical Doctor 35, 5051.CrossRefGoogle ScholarPubMed
Kassi, M, Tareen, I, Qazi, A and Kasi, PM (2004) Fine-needle aspiration cytology in the diagnosis of cutaneous leishmaniasis. Annals of Saudi Medicine 24, 9397.CrossRefGoogle Scholar
Kassi, M, Kassi, M, Afghan, AK, Rehman, R and Kasi, PM (2008) Marring leishmaniasis: the stigmatization and the impact of cutaneous leishmaniasis in Pakistan and Afghanistan. PLOS Neglected Tropical Diseases 2, e259.CrossRefGoogle ScholarPubMed
Katakura, K (2009) Molecular epidemiology of leishmaniasis in Asia (focus on cutaneous infections). Current Opinion in Infectious Diseases 22, 126130.CrossRefGoogle Scholar
Khan, NH, ul Bari, A, Hashim, R, Khan, I, Muneer, A, Shah, A, Wahid, S, Yardley, V, O'Neil, B and Sutherland, CJ (2016) Cutaneous leishmaniasis in Khyber Pakhtunkhwa province of Pakistan: clinical diversity and species-level diagnosis. American Journal of Tropical Medicine and Hygiene 95, 11061114.CrossRefGoogle ScholarPubMed
Khan, A, Afzal, MS and Ahmed, H (2019) Leishmaniasis in Pakistan: a call for action. Travel Medicine and Infectious Disease 32, 101516.CrossRefGoogle Scholar
Llanos-Cuentas, A, Tulliano, G, Araujo-Castillo, R, Miranda-Verastegui, C, Santamaria-Castrellon, G, Ramirez, L, Lazo, M, De Doncker, S, Boelaert, M, Robays, J and Dujardin, JC (2008) Clinical and parasite species risk factors for pentavalent antimonial treatment failure in cutaneous leishmaniasis in Peru. Clinical Infectious Diseases 46, 223231.CrossRefGoogle ScholarPubMed
Mughal, TM (2014) Cutaneous Leishmaniasis and assessment of environmental risk factors in Mirpur AJK. Journal of Rawalpindi Medical College 18, 110113.Google Scholar
Nawaz, R, Khan, AM, Khan, SU and Rauf, A (2010) Frequency of cutaneous leishmaniasis in an Afghan refugee camp at Peshawar. Gomal Journal of Medical Sciences 8, 1619.Google Scholar
Özbilgin, A, Töz, S, Harman, M, Topal, SG, Uzun, S, Okudan, F, Güngör, D, Erat, A, Ertabaklar, H, Ertuğ, S and Gündüz, C (2019) The current clinical and geographical situation of cutaneous leishmaniasis based on species identification in Turkey. Acta Tropica 190, 5967.CrossRefGoogle ScholarPubMed
Qureshi, NA, Ali, A, Rashid, U and Ali, N (2016) Prevalence of Leishmania tropica in schoolboys of Khyber agency, FATA near Pak-Afghan border. Acta Tropica 164, 9094.CrossRefGoogle ScholarPubMed
Rahman, HU and Rehman, AU (2017) Cutaneous leishmaniasis in Dir Lower District, North-West Pakistan: epidemiology and treatment response. Journal of Pakistan Association of Dermatologists 27, 353362.Google Scholar
Salman, SM, Rubeiz, NG and Kibbi, AG (1999) Cutaneous leishmaniasis: clinical features and diagnosis. Clinics in Dermatology 17, 291296.CrossRefGoogle ScholarPubMed
Shaheen, N, Qureshi, NA, Qureshi, MZ, Fatima, H, Afzal, M and Alhewairini, SS (2020) Molecular epidemiological survey of cutaneous leishmaniasis from Azad Jammu and Kashmir, Pakistan. Acta Tropica, 206, 105434.CrossRefGoogle ScholarPubMed
Shakila, A, Bilqees, FM, Salim, A and Moinuddin, M (2006) Geographical distribution of cutaneous leishmaniasis and sand flies in Pakistan. Turkish Journal of Parasitology 30, 16.Google Scholar
Shamsuddin, S, Mengal, JA, Gazozai, S, Mandokhail, ZK, Kasi, M, Muhammad, N and Ahmad, SB (2017) Atypical presentation of cutaneous leishmaniasis in the native population of Balochistan. Journal of Pakistan Association of Dermatologists 16, 196200.Google Scholar
Simon Brooker, NM, Adil, K, Agha, S, Reithinger, R, Rowland, M, Ali, I and Kolaczinski, J (2004) Leishmaniasis in refugee and local Pakistani populations. Emerging Infectious Diseases 10, 1681.CrossRefGoogle Scholar
Sinha, PK, Pandey, K and Bhattacharya, SK (2005) Diagnosis & management of leishmania/HIV co-infection. Indian Journal of Medical Research 121, 407414.Google ScholarPubMed
Talari, SA, Talaei, R, Shajari, G, Vakili, Z and Taghaviardakani, A (2006) Childhood cutaneous leishmaniasis: report of 117 cases from Iran. Korean Journal of Parasitology 44, 355.CrossRefGoogle ScholarPubMed
Torres-Guerrero, E, Quintanilla-Cedillo, MR, Ruiz-Esmenjaud, J and Arenas, R (2017) Leishmaniasis: a review. F1000Research 6, 750.CrossRefGoogle ScholarPubMed
Tsukayama, P, Núñez, JH, De Los Santos, M, Soberón, V, Lucas, CM, Matlashewski, G, Llanos-Cuentas, A, Ore, M, Baldeviano, GC, Edgel, KA and Lescano, AG (2013) A FRET-based real-time PCR assay to identify the main causal agents of New World tegumentary leishmaniasis. PLOS Neglected Tropical Diseases 7, e1956.CrossRefGoogle ScholarPubMed
Uzun, S, Gürel, MS, Durdu, M, Akyol, M, Fettahlıoğlu Karaman, B, Aksoy, M, Aytekin, S, Borlu, M, İnan Doğan, E, Doğramacı, ÇA and Kapıcıoğlu, Y (2018) Clinical practice guidelines for the diagnosis and treatment of cutaneous leishmaniasis in Turkey. International Journal of Dermatology 57, 973982.CrossRefGoogle ScholarPubMed
Weirather, JL, Jeronimo, SM, Gautam, S, Sundar, S, Kang, M, Kurtz, MA, Haque, R, Schriefer, A, Talhari, S, Carvalho, EM and Donelson, JE (2011) Serial quantitative PCR assay for detection, species discrimination, and quantification of Leishmania spp. in human samples. Journal of Clinical Microbiology 49, 38923904.CrossRefGoogle ScholarPubMed
World Health Organization (2010) Control of the Leishmaniases: Report of a Meeting of the WHO Expert Committee on the Control of Leishmaniases, 22–26 March 2010. Geneva: World Health Organization.Google Scholar
World Health Organization (2020) Leishmaniasis. https://www.who.int/leishmaniasis/burden/en/ (Accessed 19 March 2020).Google Scholar
Yohannes, M, Abebe, Z and Boelee, E (2019) Prevalence and environmental determinants of cutaneous leishmaniasis in rural communities in Tigray, northern Ethiopia. PLOS Neglected Tropical Diseases 13, e0007722.CrossRefGoogle ScholarPubMed
Zijlstra, EE (2016) The immunology of post-kala-azar dermal leishmaniasis (PKDL). Parasites Vectors 9, 464.CrossRefGoogle Scholar
Figure 0

Table 1. Description of the study sites

Figure 1

Fig. 1. (a–f) Atypical forms of Cutaneous Leishmaniasis (CL) lesions. (a) Papulonodular lesions, dry type; (b) Ulcerated lesion, dry type; (c) Discoid lupus erythematosus, dry type; (d) Psoriasiform lesion, dry type; (e) Mycetomatous, dry type; (f) Erysipeloid, dry type.

Figure 2

Table 2. Distribution and prevalence of CL in different age groups and gender for the years 2018 and 2019

Figure 3

Fig. 2. Prevalence of CL according to gender and age Left: Prevalence of CL by age groups with 95% confidence limits for the year 2019. Right: Prevalence of CL by age groups with 95% confidence limits for the year 2018.

Figure 4

Fig. 3. Number and percentageof male and female patients with active lesions in 2018 and 2019.

Figure 5

Table 3. Monthly distribution of CL cases for the years of 2018 and 2019